相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors
Allison M. Quick et al.
SUPPORTIVE CARE IN CANCER (2020)
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer
Gabriella Martino et al.
PLOS ONE (2020)
Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study
Maurizio Filippini et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2020)
A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial
Marie Fidela R. Paraiso et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2020)
Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results
Stavros Athanasiou et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2019)
The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis
Swati Jha et al.
CLINICAL BREAST CANCER (2019)
Vaginal CO2 laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study
Antonia Pearson et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Joint recommendations for the diagnosis and treatment of vulvo-vaginal atrophy in women in the peri- and post-menopausal phases from the Societa Italiana per la Menopausa (SIM) and the Societa Italiana della Terza Eta (SIGiTE)
Angelo Cagnacci et al.
MINERVA GINECOLOGICA (2019)
Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors
Annalisa Pieralli et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?
Nicoletta Biglia et al.
CLINICAL BREAST CANCER (2015)
Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study
Stefano Salvatore et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2015)
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study
S. Salvatore et al.
CLIMACTERIC (2014)
Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: A randomised, placebo-controlled, phase III trial
D. Portman et al.
MATURITAS (2014)
Locating Pain in Breast Cancer Survivors Experiencing Dyspareunia A Randomized Controlled Trial
Martha F. Goetsch et al.
OBSTETRICS AND GYNECOLOGY (2014)
Microablative fractional CO2 laser improves dyspareunia related to vulvovaginal atrophy: a pilot study
Stefano Salvatore et al.
JOURNAL OF ENDOMETRIOSIS AND PELVIC PAIN DISORDERS (2014)
Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial
Mia Fahlen et al.
EUROPEAN JOURNAL OF CANCER (2013)
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Christina Davies et al.
LANCET (2013)
Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy
David J. Portman et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2013)
The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI
R. E. Nappi et al.
CLIMACTERIC (2012)
Quality of Life, Fertility Concerns, and Behavioral Health Outcomes in Younger Breast Cancer Survivors: A Systematic Review
Jessica Howard-Anderson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer
Juliane Baumgart et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Vaginal pH-Balanced Gel for the Control of Atrophic Vaginitis Among Breast Cancer Survivors A Randomized Controlled Trial
Yoo-Kyung Lee et al.
OBSTETRICS AND GYNECOLOGY (2011)
Incidence and Time Course of Bleeding After Long-Term Amenorrhea After Breast Cancer Treatment A Prospective Study
Paniti Sukumvanich et al.
CANCER (2010)
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
Mitch Dowsett et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Vulvovaginal Atrophy
Maire B. Mac Bride et al.
MAYO CLINIC PROCEEDINGS (2010)
Quality of Life after Breast Cancer: Survivorship and Sexuality
Don S. Dizon
BREAST JOURNAL (2009)
Ospemifene inhibits the growth of dimethylbenzanthracene-induced mammary tumors in Sencar mice
GT Wurz et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Menopausal hormone therapy after breast cancer: The Stockholm randomized trial
E von Schoultz et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ
R Namba et al.
BREAST CANCER RESEARCH (2005)
In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer
TL Taras et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2001)
分享论文
